TGFBR1, transforming growth factor beta receptor 1, 7046
N. diseases: 347; N. variants: 47
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 9 | 99142683 | missense variant | T/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.800 | 1.000 | 12 | 2005 | 2017 | ||||||||
|
1.000 | 0.120 | 9 | 99146553 | missense variant | A/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.800 | 1.000 | 12 | 2005 | 2017 | ||||||||
|
1.000 | 0.120 | 9 | 99137883 | missense variant | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.800 | 1.000 | 12 | 2005 | 2017 | ||||||||
|
0.882 | 0.120 | 9 | 99149253 | missense variant | G/A;C;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.800 | 1.000 | 7 | 2011 | 2017 | ||||||||
|
0.882 | 0.120 | 9 | 99149253 | missense variant | G/A;C;T | snv |
|
0.700 | 1.000 | 7 | 2005 | 2012 | |||||||||
|
0.882 | 0.120 | 9 | 99149253 | missense variant | G/A;C;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 6 | 2006 | 2012 | ||||||||
|
1.000 | 0.120 | 9 | 99137962 | inframe deletion | AAG/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 4 | 2008 | 2015 | ||||||||
|
0.851 | 0.120 | 9 | 99123789 | intron variant | T/C | snv | 6.5E-02 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||||
|
0.851 | 0.120 | 9 | 99123789 | intron variant | T/C | snv | 6.5E-02 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||||
|
0.851 | 0.160 | 9 | 99105256 | inframe insertion | GCGGCGGCGGCGGCG/-;GCG;GCGGCG;GCGGCGGCG;GCGGCGGCGGCG;GCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCGGCG | delins |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||||||
|
1.000 | 0.040 | 9 | 99146083 | intron variant | T/G | snv | 0.25 |
|
Eye Diseases | 0.810 | 1.000 | 2 | 2013 | 2019 | |||||||
|
0.851 | 0.160 | 9 | 99149374 | 3 prime UTR variant | A/G | snv | 0.17 |
|
Digestive System Diseases; Infections | 0.020 | 0.500 | 2 | 2014 | 2017 | |||||||
|
0.851 | 0.120 | 9 | 99123789 | intron variant | T/C | snv | 6.5E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 9 | 99123789 | intron variant | T/C | snv | 6.5E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 9 | 99145142 | intron variant | G/A | snv | 0.21 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 9 | 99145142 | intron variant | G/A | snv | 0.21 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 9 | 99108020 | intron variant | T/C | snv | 0.22 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.160 | 9 | 99105256 | inframe insertion | GCGGCGGCGGCGGCG/-;GCG;GCGGCG;GCGGCGGCG;GCGGCGGCGGCG;GCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCGGCG | delins |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 | ||||||||
|
0.851 | 0.160 | 9 | 99105256 | inframe insertion | GCGGCGGCGGCGGCG/-;GCG;GCGGCG;GCGGCGGCG;GCGGCGGCGGCG;GCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCGGCG | delins |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 | ||||||||
|
0.851 | 0.160 | 9 | 99105256 | inframe insertion | GCGGCGGCGGCGGCG/-;GCG;GCGGCG;GCGGCGGCG;GCGGCGGCGGCG;GCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCGGCG | delins |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 | ||||||||
|
0.851 | 0.160 | 9 | 99105256 | inframe insertion | GCGGCGGCGGCGGCG/-;GCG;GCGGCG;GCGGCGGCG;GCGGCGGCGGCG;GCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCG;GCGGCGGCGGCGGCGGCGGCGGCGGCG | delins |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
9 | 99105926 | intron variant | C/G | snv | 2.1E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 99105926 | intron variant | C/G | snv | 2.1E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 99105926 | intron variant | C/G | snv | 2.1E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 99105926 | intron variant | C/G | snv | 2.1E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |